Predicted metabolite levels for each reaction intermediate shown in Figure 7 under conditions in which the NAD+:NADH ratio is 31 (Bennett et al. [26]), or decreased by either 0.1-f... by William R. Cannon (608586)

Relative fold change (relative to untreated control cells) of the <i>HER-2</i> gene among LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

Subjects:

Relative fold change (relative to untreated control cells) of the <i>PTGS-2</i> gene among LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

Subjects:

HCMV US27 correlates with decreased expression of p21 and Sestrin-2. by Carolyn C. Tu (663652)

Western blot analysis demonstrating the expression of EGFR, HER-2 and COX-2 proteins in LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

Subjects:

Folding and stability of GDAP1 as affected by CMT mutations. by Aleksi Sutinen (10039145)

Subjects:

Heatmap of metabolites with at least 1.5-fold change (increase or decrease) from 0h following treatment with or without PMA for 5 and 15 min. by Susama Chokesuwattanaskul (5813888)

Primer sequences used for the real time PCR of the genes <i>EGFR</i>, <i>HER-2</i> and <i>PTGS-2</i>. by Asadollahi Parisa (8837432)

Subjects:

Predicted steady state distribution of the percent of TDLs in a 1) control animal, 2) following increased in the average residence time of lymphocytes in the lung (20 fold, from 26 seconds to 9 minutes) due to, for example, inflammation in the lung; 3) following a decreased entrance rate of TDLs into lymph nodes and Peyer's patches (20 fold, e.g., by using anti CD62L antibody); 4) following a decreased exit rate of TDLs from lymph nodes and Peyer's patches (5 fold, e.g., using FTY720). by Vitaly V. Ganusov (142019)

Pre-treatment of IOZCAS-Spex-II cells with CPT and HCPT decreased Topo1 specific activity in a time-dependent manner. by Lan Zhang (90951)

Response of small airway tissues infected with EV-D94 and decreasing doses of EV-D68. by Ines Cordeiro Filipe (5849144)

“…<p>Tissues were infected with 1E7 RNA copies of EV-D94 (equivalent to 2,46E4 TCID50) and 1E7 RNA copies of EV-D68 (3,3E5 TCID50) as well as decreasing doses of the latter. …”

GSK343 decreased neuroblastoma viability, proliferation, and motility. by Laura V. Bownes (10276762)

“…<p>(A) SK-N-AS, SK-N-BE(2), SH-EP and WAC(2) cells (1.5 × 10³ cells) were treated with increasing concentrations of GSK343 (0, 5, 15, 25 μM) for 24 hours and viability was measured using alamarBlue^® assay. …”

Transcription of a plasmid-borne copy of the <i>mgtC</i> gene from a heterologous promoter reduces protein synthesis. by Carissa Chan (18310140)

Subjects:

Illustrations of the SeqFold2D network and the Stralign dataset. by Xiangyun Qiu (316117)

MEK5 expression decreases ER signaling and confers endocrine resistance. by James W. Antoon (444010)

Decreased expression of HATL5 mRNA and protein in human carcinomas. by Gregory S. Miller (519005)

HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…However, transfection of SUZ12 siRNA significantly reduced endothelial branching compared to HG+control siRNA. [NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”

Structure of ADPR2 and ACER3. by Jae Kyo Yi (13570063)

Forty-two receptors arranged in order of decreasing interaction with the full set of thirty-five drugs. by Thomas S. Ray (253767)

“…<p>The forty-two receptors are arranged in order of decreasing interaction with the full set of thirty-five drugs, based on the breadth statistics, B, B_sq. and B_exp. …”

S1 Raw images - by Asadollahi Parisa (8837432)

Subjects: